Drug Manufacturers - General
Stocks Ranked by
Market Capitalization

Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs.

#	Name	Market cap	Price	Price change %
1	1 Eli Lilly LLY $683B	$683B	$761.59	0.19%
2	2 Johnson & Johnson JNJ $420B	$420B	$174.56	1.49%
3	3 AbbVie ABBV $391B	$391B	$221.52	0.32%
4	4 Novo Nordisk NVO $275B	$275B	$61.78	6.15%
5	5 AstraZeneca AZN $238B	$238B	$76.86	1.07%
6	6 Novartis NVS $237B	$237B	$122.57	0.08%
7	7 Merck MRK $203B	$203B	$81.42	0.35%
8	8 Amgen AMGN $148B	$148B	$275.53	0.3%
9	9 Gilead Sciences GILD $141B	$141B	$113.56	1.16%
10	10 Pfizer PFE $137B	$137B	$24.13	0.33%
11	11 Sanofi SNY $116B	$116B	$47.62	1.38%
12	12 Bristol-Myers Squibb BMY $92.7B	$92.7B	$45.56	1.28%
13	13 GSK GSK $81.1B	$81.1B	$40.28	0.2%
14	14 Biogen BIIB $21.2B	$21.2B	$144.67	0.14%
15	15 Grifois GRFS $6.66B	$6.66B	$9.79	0.41%
16	16 Organon & Co OGN $2.8B	$2.8B	$10.77	3.06%
17	17 Lineage Cell Therapeutics LCTX $352M	$352M	$1.54	10.8%
18	AMRN 18 Amarin Corp AMRN $308M	$308M	$14.88	1.92%
19	19 Scilex Holding SCLX $176M	$176M	$25.29	1.32%
20	20 Protalix BioTherapeutics PLX $148M	$148M	$1.85	1.07%
21	CYBN 21 Cybin CYBN $141M	$141M	$5.99	0.17%
22	22 Armata Pharmaceuticals ARMP $106M	$106M	$2.92	1.35%
23	PTHS 23 Pelthos Therapeutics Inc. PTHS $98.1M	$98.1M	$32.25	1.35%
24	24 Xtant Medical Holdings XTNT $89M	$89M	$0.6355	2.23%
25	NSRX 25 Nasus Pharma Ltd. NSRX $72.8M	$72.8M	$8.04	1.11%